Related Experiment Video
Updated: Jun 5, 2026

Development and Application of Rapamycin-regulated Tyrosine Phosphatases
Published on: September 6, 2024
Deficiency of Rap1-binding protein RAPL causes lymphoproliferative disorders through mislocalization of p27kip1
Koko Katagiri1, Yoshihiro Ueda, Takashi Tomiyama
1Department of Life Science, School of Science and Technology, Kwanseigakuen University, and JST, CREST, 2-1 Gakuen, Sanda, Hyogo 669-1337, Japan.
Abstract:
RAPL (an alternative spliced form of Rassf5) is a critical Ras-related protein1 (Rap1) effector that regulates lymphocyte adhesion. Here, we have shown that in addition to this previously described function, RAPL also negatively controls lymphocyte proliferation and prevents autoimmunity and lymphoma. RAPL-deficient mice experienced age-related lupus-like glomerulonephritis and developed B cell lymphomas. RAPL-deficient lymphocytes showed hyperproliferation by enhanced S phase entry after antigen receptor ligation. Compared to wild-type cells, RAPL-deficient naive lymphocytes had a 2- to 3-fold increase in Cdk2 kinase activity with a cytoplasmic mislocalization of the cyclin-dependent kinase inhibitor p27(kip1). RAPL was found to suppress the phosphorylation of p27(kip1) on serine 10 (S10) and promoted p27(kip1) nuclear translocation. An S10A mutation in p27(kip1) corrected its cytoplasmic accumulation, reduced hyperproliferation in RAPL-deficient lymphocytes, and suppressed glomerulonephritis and development of B cell lymphoma. Thus, RAPL serves as a checkpoint for S phase entry to prevent lymphoproliferative disorders through the spatial regulation of p27(kip1).
Insights
RAPL protein regulates lymphocyte adhesion and proliferation. Its deficiency leads to autoimmune diseases and lymphoma by disrupting cell cycle control via p27(kip1) regulation.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- RAPL (Ras-associated protein 1) is a known Rap1 effector regulating lymphocyte adhesion.
- Its role in controlling lymphocyte proliferation and preventing lymphoproliferative disorders remains largely unexplored.
Purpose of the Study:
- To investigate the novel function of RAPL in regulating lymphocyte proliferation and preventing autoimmunity and lymphoma.
- To elucidate the molecular mechanism by which RAPL controls cell cycle progression.
Main Methods:
- Utilized RAPL-deficient mouse models to study lymphocyte behavior and disease development.
- Analyzed cell cycle progression, Cdk2 kinase activity, and p27(kip1) localization in lymphocytes.
- Employed site-directed mutagenesis (S10A mutation) in p27(kip1) to assess its functional impact.
Main Results:
- RAPL-deficient mice developed lupus-like glomerulonephritis and B cell lymphomas.
- RAPL-deficient lymphocytes exhibited hyperproliferation due to enhanced S phase entry.
- RAPL suppresses p27(kip1) phosphorylation at S10, promoting its nuclear translocation and inhibiting Cdk2 activity.
Conclusions:
- RAPL acts as a critical checkpoint for S phase entry, preventing lymphoproliferative disorders.
- The spatial regulation of p27(kip1) by RAPL is crucial for maintaining immune homeostasis.
- Targeting the RAPL-p27(kip1) pathway may offer therapeutic strategies for autoimmune diseases and lymphoma.
More Related Videos
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
10:27Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
The JAK-STAT Signaling Pathway
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...